Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVT29 vs Eylea HD in Diabetic Macular Edema
NCT07489131Phase 3Recruiting
- Sponsor
- Alvotech
- Start
- Apr 2026
- Primary completion
- Jul 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of avt29 in diabetic macular edema (DME), sponsored by Alvotech. Started Apr 2026; status: recruiting.
02
Drugs
avt29
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07489131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07489131.